Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.77

+1.6%

2:41 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (10021)	1/14/2004 3:06:36 PM
From: zeta1961	Read Replies (1) of 52153

Hi Peter, I've not followed it long enough and close enough...but a virologist and hepatologist alerted me to it earlier this year...he's quite bullish on Zadaxin...thanks for the heads up re: mgt...can either make or break a good thing...Zadaxin data I've seen are quite impressive(if there's a bug I know most...it's HepB and C because of it's risk for health care professionals...several colleagues have accidentally contracted C on the job... Chiron(don't own) just announced collaboration with an Australian biotech to develop a HepC vaccine...I realize Chiron is the champion of HepC...a big GOOD LUCK to them...it mutates too frenetically...even the several known species have subspecies...with geographic variants... biz.yahoo.com Regards...Zeta....Finding a HepC co. that actually makes some headway will make an investor very happy:)...not to say the millions affected...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next